SCHEMBL19988801

SCHEMBL19988801

COC(=O)c1cccnc1-c1cc2[nH]c3ccccc3c2c2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.47
▸ LMNA P02545 3/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ MAPT P10636 2/20 0.47
▸ HPGD P15428 2/20 0.47
▸ HSD17B10 Q99714 2/20 0.47
▸ GABRA1 P14867 2/20 0.47
▸ GABRG2 P18507 2/20 0.47
▸ GABRB3 P28472 2/20 0.47
▸ GABRA5 P31644 2/20 0.47
▸ GABRA3 P34903 2/20 0.47
▸ GABRA2 P47869 2/20 0.47
▸ GABRP O00591 1/20 0.47
▸ GABRD O14764 1/20 0.47
▸ PDE5A O76074 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ PKM P14618 1/20 0.47
▸ GABRB1 P18505 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21155928 0.83 KIF11 (0.51) KDM4ELMNAALDH1A1MAPTHPGD
SCHEMBL19988802 0.82 MAPT (0.48) KDM4ELMNAALDH1A1MAPTHPGD
SCHEMBL19988471 0.82 SMN1; SMN2 (0.39) KDM4ELMNAALDH1A1MAPTHPGD
SCHEMBL19988468 0.80 MAP2K1 (0.49) KDM4ELMNAALDH1A1MAPTHPGD
SCHEMBL19988800 0.79 KDM4E (0.47) KDM4ELMNAALDH1A1MAPTHPGD
SCHEMBL19988799 0.79 KDM4E (0.47) KDM4ELMNAALDH1A1MAPTHPGD
SCHEMBL29520873 0.78 KDM4E (0.45) KDM4ELMNAALDH1A1MAPTHPGD
SCHEMBL19988459 0.76 KDM4E (0.44) KDM4ELMNAALDH1A1MAPTHPGD
SCHEMBL19988466 0.76 KDM4E (0.44) KDM4ELMNAALDH1A1MAPTHPGD
SCHEMBL19988451 0.75 KDM4E (0.41) KDM4ELMNAGABRA1GABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512848-B1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2020-11-18 — — EP disclosed
US-20190214574-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2019-07-11 — — US disclosed
WO-2018050583-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2018-03-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190214574-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES CYCS, CYP3A4, CYP2E1 KDM4E 2638/4885LMNA 4437/4885ALDH1A1 506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback